Development and evaluation of an information booklet/decision-making guide for patients with colorectal cancer considering therapy in addition to surgery
Corresponding Author
M. JEFFORD mbbs , mhlthservmt , phd , fracp
Peter MacCallum Cancer Centre, East Melbourne, Victoria, and the Cancer Information and Support Service, The Cancer Council Victoria, Melbourne, Victoria,
Dr Michael Jefford, Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Locked Bag 1, A’Beckett Street, Victoria 8006, Australia (e-mail: [email protected]).Search for more papers by this authorA. GIBBS ba, dip soc studs
Centre for Behavioural Research in Cancer, The Cancer Council Victoria, Melbourne, Victoria,
Search for more papers by this authorD. READING ba, dip ed
Cancer Education Unit, The Cancer Council Victoria, Melbourne, Victoria, Australia
Search for more papers by this authorCorresponding Author
M. JEFFORD mbbs , mhlthservmt , phd , fracp
Peter MacCallum Cancer Centre, East Melbourne, Victoria, and the Cancer Information and Support Service, The Cancer Council Victoria, Melbourne, Victoria,
Dr Michael Jefford, Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Locked Bag 1, A’Beckett Street, Victoria 8006, Australia (e-mail: [email protected]).Search for more papers by this authorA. GIBBS ba, dip soc studs
Centre for Behavioural Research in Cancer, The Cancer Council Victoria, Melbourne, Victoria,
Search for more papers by this authorD. READING ba, dip ed
Cancer Education Unit, The Cancer Council Victoria, Melbourne, Victoria, Australia
Search for more papers by this authorAbstract
The aim of this project was to develop and evaluate a decision-making guide for patients with colorectal cancer contemplating adjuvant therapy. Initially, a focus group was held, and then a draft booklet was developed, which was reviewed by patients and professionals. A subsequent revised booklet and a questionnaire were mailed to 24 patients and 32 professionals for evaluation. Further changes resulted in the final 100-page decision-making guide, which had a Flesch-Kincaid reading level of 8.0 and DISCERN rating 5. Seventeen patients (71%) and 22 professionals (69%) completed the questionnaire. All patients agreed/strongly agreed the guide was ‘informative’ and ‘written in a way you like’ and 94% considered it ‘helpful for making decisions’. Professionals found it ‘informative’ (95%), ‘written in a pleasing style’ (95%), ‘easy to understand’ (91%) and felt it would ‘help patients make decisions’ (76%), ‘be appropriate to give to patients’ (91%) and would ‘improve patient knowledge and preparedness’ (100%). Further work aims to assess the impact of the guide upon patient outcomes.
REFERENCES
- Australian Bureau of Statistics (1999) Year Book Australia, 1999 (ABS Catalogue No. 1301.0). Australian Bureau of Statistics, Canberra, Australia.
- Australian Bureau of Statistics (2002) Census of Population and Housing: Selected Education and Labour Force Characteristics for Statistical Local Areas, Victoria (ABS Catalogue No. 2017.2). Australian Bureau of Statistics, Canberra, Australia.
- Benson A.B. 3rd,Choti M.A., Cohen A.M., Doroshow J.H., Fuchs C., Kiel K., Martin E.W. Jr, McGinn C., Petrelli N.J., Posey J.A., Skibber J.M., Venook A. & Yeatman T.J. (2000a) NCCN practice guidelines for colorectal cancer. Oncology (Huntingt) 14, 203–212.
- Benson A.B. 3rd,Desch C.E., Flynn P.J., Krause C., Loprinzi C.L., Minsky B.D., Petrelli N.J., Pfister D.G., Smith T.J. & Somerfield M.R. (2000b) 2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. Journal of Clinical Oncology 18, 3586–3588.
- Bruera E., Sweeney C., Calder K., Palmer L. & Benisch-Tolley S. (2001) Patient preferences versus physician perceptions of treatment decisions in cancer care. Journal of Clinical Oncology 19, 2883–2885.
- Bruera E., Willey J.S., Palmer J.L. & Rosales M. (2002) Treatment decisions for breast carcinoma: patient preferences and physician perceptions. Cancer 94, 2076–2080.
- Carrick S.E., Bonevski B., Redman S., Simpson J., Sanson-Fisher R.W. & Webster F. (1998) Surgeons’ opinions about the NHMRC clinical practice guidelines for the management of early breast cancer. Medical Journal of Australia 169, 300–305.
- Charnock D., Shepperd S., Needham G. & Gann R. (1999) DISCERN: an instrument for judging the quality of written consumer health information on treatment choices. Journal of Epidemiology Community Health 53, 105–111.
- Cooley M.E., Moriarty H., Berger M.S., Selm-Orr D., Coyle B. & Short T. (1995) Patient literacy and the readability of written cancer educational materials. Oncology Nursing Forum 22, 1345–1351.
- Coulter A. (1997) Partnerships with patients: the pros and cons of shared clinical decision-making. Journal of Health Service Research Policy 2, 112–121.
- Coulter A., Entwistle V. & Gilbert D. (1999) Sharing decisions with patients: is the information good enough? British Medical Journal 318, 318–322.
-
Dowsett S.M.,
Saul J.L.,
Butow P.N.,
Dunn S.M.,
Boyer M.J.,
Findlow R. &
Dunsmore J. (2000) Communication styles in the cancer consultation: preferences for a patient-centred approach.
Psychooncology
9, 147–156.
10.1002/(SICI)1099-1611(200003/04)9:2<147::AID-PON443>3.0.CO;2-X CAS PubMed Web of Science® Google Scholar
- Duric V. & Stockler M. (2001) Patients’ preferences for adjuvant chemotherapy in early breast cancer: a review of what makes it worthwhile. Lancet Oncology 2, 691–697.
- Edwards A., Elwyn G. & Mulley A. (2002) Explaining risks: turning numerical data into meaningful pictures. British Medical Journal 324, 827–830.
- Fallowfield L., Ford S. & Lewis S. (1995) No news is not good news: information preferences of patients with cancer. Psychooncology 4, 197–202.
- Fallowfield L.J., Hall A., Maguire G.P. & Baum M. (1990) Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial. British Medical Journal 301, 575–580.
- Gattellari M., Ward J. & Solomon M. (2001) Implementing guidelines about colorectal cancer: a national survey of target groups. ANZ Journal of Surgery 71, 147–153.
- Haydon A. (2003) Adjuvant chemotherapy in colon cancer: what is the evidence? Internal Medicine Journal 33, 119–124.
- Health Issues Centre (2001) Interviews with Consumers and Carers about Their Experience of Care for the Treatment of Colorectal Cancer. Clinical Support Systems Project. Austin Consortium, Melbourne, Victoria, Australia.
- Jackson C.L. & De Jong I.C. (2001) Clinicians and guidelines: leading a horse to water. Medical Journal of Australia 174, 267–268.
- Jefford M. & Tattersall M.H. (2002) Informing and involving cancer patients in their own care. Lancet Oncology 3, 629–637.
- Kaplan S.H., Greenfield S. & Ware J.E. Jr (1989) Assessing the effects of physician–patient interactions on the outcomes of chronic disease. Medical Care 27, S110–S127.
- Langer A.S. (2001) Side effects, quality-of-life issues, and trade-offs: the patient perspective. Journal of the National Cancer Institute. Monographs 30, 125–129.
- Leighl N., Gattellari M., Butow P., Brown R. & Tattersall M.H. (2001) Discussing adjuvant cancer therapy. Journal of Clinical Oncology 19, 1768–1778.
- Long P.W., Larkins R.G., Patterson C.G. & Hyde J. (2001) Facilitating best practice: transferring the lessons of the Clinical Support Systems Program. Journal of Quality Clinical Practice 21, 157–159.
- Mahoney T., Kuo Y.H., Topilow A. & Davis J.M. (2000) Stage III colon cancers: why adjuvant chemotherapy is not offered to elderly patients. Archives of Surgery 135, 182–185.
-
Mandelblatt J.S.,
Yabroff K.R. &
Kerner J.F. (1999) Equitable access to cancer services: a review of barriers to quality care.
Cancer
86, 2378–2390.
10.1002/(SICI)1097-0142(19991201)86:11<2378::AID-CNCR28>3.0.CO;2-L CAS PubMed Web of Science® Google Scholar
- Molenaar S., Sprangers M.A., Postma-Schuit F.C., Rutgers E.J., Noorlander J., Hendriks J. & De Haes H.C. (2000) Feasibility and effects of decision aids. Medical Decision Making 20, 112–127.
- National Health and Medical Research Council (NHMRC) (1999) Guidelines for the Prevention, Early Detection and Management of Colorectal Cancer. AGPS, Canberra, Australia.
- Newcomb P.A. & Carbone P.P. (1993) Cancer treatment and age: patient perspectives. Journal of the National Cancer Institute 85, 1580–1584.
- O'Connor A.M., Stacey D., Rovner D., Holmes-Rovner M., Tetroe J., Llewellyn-Thomas H., Entwistle V., Rostom A., Fiset V., Barry M. & Jones J. (2001) Decision aids for people facing health treatment or screening decisions. Cochrane Database of Systematic Reviews CD001431.
- Parkin D.M. (2001) Global cancer statistics in the year 2000. Lancet Oncology 2, 533–543.
- Raich P.C., Plomer K.D. & Coyne C.A. (2001) Literacy, comprehension, and informed consent in clinical research. Cancer Investigation 19, 437–445.
- Rees C.E., Ford J.E. & Sheard C.E. (2002) Evaluating the reliability of DISCERN: a tool for assessing the quality of written patient information on treatment choices. Patient Education and Counseling 47, 273–275.
- Rubin J. (1994) Handbook of Usability Testing: How to Plan, Design, and Conduct Effective Tests. John Wiley & Sons, New York, NY, USA.
- Saltz L.B. & Minsky B. (2002) Adjuvant therapy of cancers of the colon and rectum. Surgical Clinics North America 82, 1035–1058.
-
Sanson-Fisher R.,
Girgis A.,
Boyes A.,
Bonevski B.,
Burton L. &
Cook P. (2000) The unmet supportive care needs of patients with cancer. Supportive Care Review Group.
Cancer
88, 226–237.
10.1002/(SICI)1097-0142(20000101)88:1<226::AID-CNCR30>3.0.CO;2-P CAS PubMed Web of Science® Google Scholar
- Schrag D., Cramer L.D., Bach P.B. & Begg C.B. (2001a) Age and adjuvant chemotherapy use after surgery for stage III colon cancer. Journal of the National Cancer Institute 93, 850–857.
- Schrag D., Gelfand S.E., Bach P.B., Guillem J., Minsky B.D. & Begg C.B. (2001b) Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results – Medicare. Journal of Clinical Oncology 19, 3712–3718.
- Schwartz L.M., Woloshin S. & Welch H.G. (1999) Risk communication in clinical practice: putting cancer in context. Journal of the National Cancer Institute. Monographs 25, 124–133.
- Shumay D.M., Maskarinec G., Gotay C.C., Heiby E.M. & Kakai H. (2002) Determinants of the degree of complementary and alternative medicine use among patients with cancer. Journal of Alternative Complementary Medicine 8, 661–671.
- Simes R.J. & Coates A.S. (2001) Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed? Journal of the National Cancer Institute. Monographs 30, 146–152.
- Street R.L. Jr & Voigt B. (1997) Patient participation in deciding breast cancer treatment and subsequent quality of life. Medical Decision Making 17, 298–306.
- Sundararajan V., Grann V.R., Jacobson J.S., Ahsan H. & Neugut A.I. (2001) Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: a population-based study. Cancer Journal 7, 213–218.
- Whelan T., Sawka C., Levine M., Gafni A., Reyno L., Willan A., Julian J., Dent S., Abu-Zahra H., Chouinard E., Tozer R., Pritchard K. & Bodendorfer I. (2003) Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancer. Journal of the National Cancer Institute 95, 581–587.
- Yellen S.B., Cella D.F. & Leslie W.T. (1994) Age and clinical decision making in oncology patients. Journal of the National Cancer Institute 86, 1766–1770.